✦ LIBER ✦

A comparison of S-adenosylmethionine (SAMe), rifampicin (R) and ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC): Interim results

✍ Scribed by Bray, GP; Di Padova, C; Tredger, JM; Williams, R

Book ID: 122805227
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 63 KB
Volume: 13
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(91)91379-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate (MTX) plus ursodeoxycholic

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis

✍ Burton Combes; Scott S. Emerson; Nancy L. Flye; Santiago J. Munoz; Velimir A. Lu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

This placebo-controlled, randomized, multicenter trial compared the effects of MTX plus UDCA to UDCA alone on the course of primary biliary cirrhosis (PBC). Two hundred and sixty five AMA positive patients without ascites, variceal bleeding, or encephalopathy; a serum bilirubin less than 3 mg/dL; se

The canadian multicenter double-blind ra

The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

✍ E. Jenny Heathcote; Karen Cauch-Dudek; Valery Walker; Robert J. Bailey; Laurence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 969 KB

Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic. Ursodeoxycholic acid is the least-known hepatotoxic bile acid, h